TMG Investigators Dr. Peter Dzongowski, Dr. Michael Jones, and Dr. Sean Peterson were all recently involved in the GSK trial AReSVi 006, evaluating a vaccine candidate for Respiratory Syncytial Virus (RSV). Recruitment was highly successful for all three investigators, whose work has helped lead to the first RSV vaccine candidate to show statistically significant and [...]
TMG Investigator Dr. Anil Gupta was recently asked to assist in the presentation of strategies for preventing COVID progression and transmission in the outpatient setting, including the latest therapeutic developments. This effort was supported by an educational grant from Merck Sharp & Dohme Corp. The presentation linked below will define the sub-populations that are most [...]
Earlier this year, we reported on the positive findings of a Covid-19 treatment study, conducted by lead study author and TMG Investigator Dr. Anil Gupta. We are now proud to highlight that as of November 18, 2021 this research has been published in the prestigious New England Journal of Medicine. It is among the most [...]
London, UK, 9 September 2021 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates, has announced positive high-level results from the MANDALA and DENALI Phase III trials of a new, fixed-dose combination inhaler for those who suffer from asthma. TMG Investigators Dr. Syed Anees, Dr. Peter Dzongowski, Dr. Anil Gupta, Dr. Sam Henein and Dr. [...]
